2382
M. Heydenreich et al. / Tetrahedron 61 (2005) 2373–2385
C
41 (20) (MKCH CON ) , 115 (31) (141–CHCH), 74 (6),
2 (8); IR: 3082, 1738, 1577, 1501, 1406, 1380, 1350, 1298,
256, 1213, 1176, 1134, 1084, 1024, 969, 939, 907, 881,
40, 808, 763, 733, 738, 610, 584, 419. Elemental analysis
1
6
1
8
calcd C 54.94, H 3.22, N 25.63; found C 54.93, H 3.19, N
25.81.
3
2
3.1.3.2. 3-Chloro-1-ethyl-1H-pyrazolo[3,4-b]quinoxa-
line (12). From 5 (2.04 g) and ethyl iodide (2.33 g) in 56%
yield as yellow prisms (hexane), mp 97–99 8C; ms: m/z (%)
(
C 62.45, H 3.82, N 26.52.
%) for C H N O: calcd C 62.26, H 3.80, N, 26.40; found
1
1 8 4
C
34 (30) (MC2) , 233 (25) (MC1) , 232 (100) M , 219
C
C
2
C
23), 217 (70) (MKCH ) , 206 (14), 204 (38) (MK
(
CH ]CH ) , 154 (8), 129 (35), 102 (23), 90 (14); IR:
3.1.2.2. 1-Acetyl-3-methyl-1H-pyrazolo[3,4-b]quin-
oxaline (8). From 2 in 88% yield as colorless needles
3
C
2
2
C
2
1
1
4
5
986, 2942, 1716, 1652, 1574, 1486, 1460, 1436, 1402,
378, 1352, 1296, 1238, 1224, 1194, 1166, 1116, 1086,
046, 982, 928, 882, 846, 794, 764, 724, 650, 618, 602, 554,
(
(
toluene), mp 191–193 8C; ms: m/z (%) 226 (9) M , 185
10), 184 (78) (MKCH CO), 183 (13), 155 (10) (184–HN ),
2
2
1
2
1
1
6
43 (54), 116 (18), 102 (17), 90 (10), 76 (11); IR: 3016,
928, 1846, 1722, 1618, 1580, 1542, 1500, 1446, 1418,
364, 1312, 1290, 1260, 1246, 1232, 1202, 1148, 1122,
096, 1038, 1010, 978., 924, 892, 834, 772, 730, 678, 634,
02, 578, 462, 420. Elemental analysis (%) for C H N O:
88, 424. Elemental analysis (%) for C H ClN : calcd C
4
11
9
6.78, H 3.90, N 24.08; found C 56.77, H 4.06, N 24.30.
3.1.3.3. 3-Chloro-1-(1-phenylethyl)-1H-pyrazolo[3,4-
b]-quinoxaline (13). From 5 (2.04 g) and (1-bromoethyl)-
1
2 10 4
calcd C 63.71, H 4.46, N 24.77; found C 63.56, H 4.48, N
4.56.
benzene (2.78 g) in 89% yield as yellow prisms (heptane),
mp 128–130 8C; ms: m/z (%) 310 (9) (MC2) , 309 (5)
2
C
C C
MC1) , 308 (19) M , 293 (8) (MKCH ), 207 (5), 206
(
(
(
3
3.1.2.3. 1-Acetyl-3-chloro-1H-pyrazolo[3,4-b]quin-
oxaline (9). From 5 in 62% yield as light brown needles
ethanol), mp 220.5–221.5 8C; ms: m/z (%) 248 (8) (MC
C
28), 205 (19), 204 (100) (MKC H CHCH ) , 177 (8), 175
6
5
2
C
10) (MKC H CHCH N ) , 169 (12) (204–Cl) , 154 (10)
C
6
C
5
2 2
(
C
C
C
) , 247 (7) (MC1) , 246 (16) M , 206 (32), 205 (12),
(169–NH) , 143 (22), 129 (16), 116 (23); IR: 3060, 2976,
2930, 2870, 1962, 1716, 1618, 1570, 1496, 1480, 1442,
2
2
1
1
1
8
C C
04 (100) (MKCH CO) , 169 (17) (204–Cl) , 143 (34),
2
1
1
7
404, 1378, 1350, 1298, 1228, 1206, 1176, 1144, 1132,
118, 1080, 1056, 1030, 1004, 982, 956, 934, 884, 850, 774,
58, 728, 716, 700, 624, 616, 602, 556, 546, 534, 490, 422.
16 (17), 102 (8), 90 (17), 76 (11), 63 (11); IR: 3062, 2888,
852, 1747, 1619, 1572, 1498, 1468, 1408, 1374, 1351,
301, 1281, 1250, 1222, 1188, 1151, 1131, 1066, 969, 918,
73, 836, 775, 725, 663, 630, 602, 571, 547, 420. Elemental
Elemental analysis (%) for C H ClN : calcd C 66.13, H
1
7
13
4
4
.24, N 18.15; found C 66.30, H 4.51, N 18.38.
analysis (%) for C H ClN O: calcd C 53.56, H 2.86, N
7
1
1
4
2
2.72; found C 53.61, H 2.86, N 23.01.
3
1
.1.4. General procedure of halogenation of substituted
H-pyrazolo[3,4-b]quinoxalines (11, 14, 16, 17). The
3.1.2.4. 1-Acetyl-3-bromo-1H-pyrazolo[3,4-b]quin-
oxaline (10). From 6 in 69% yield as light brown needles
N-Hal-compound was added slowly to a solution of the
substituted 1H-pyrazolo [3,4-b]-quinoxaline (3 mmol) in
N,N-dimethylformamide (5 mL) at room temperature with
stirring. The mixture was heated up to 80 8C and stirred at
this temperature for 10 min. After cooling the mixture was
diluted with water (5–20 mL). The solid was collected by
filtration, washed with a little amount of cold methanol and
recrystallized.
C
ethanol), mp 220–221 8C; ms: m/z (%) 293 (8) (MC3) ,
(
C
92 (21) (MC2) , 291 (8) (MC1) , 290 (21) M , 251 (9),
C
C
2
2
1
1
1
7
C
50 (100), 248 (84) (MKCH CO), 169 (42) (248–Br) ,
2
C
43 (12), 117 (12) (143–CN) , 90 (22); IR: 3063, 2934,
978, 1744, 1565, 1496, 1459, 1409, 1372, 1351, 1296,
276, 1250, 1216, 1190, 1128, 1058, 964, 916, 858, 835,
61, 727, 627, 573, 520, 419. Elemental analysis (%) for
C H BrN O: calcd C 45.38, H 2.43, N 19.25. Found C
1
1
7
4
3
.1.4.1. 3-Chloro-1-methyl-1H-pyrazolo[3,4-b]quin-
4
5.62, H 2.45, N 19.35.
oxaline (11). From TCC (1 mmol, 0.23 g) and 3 (0.55 g)
in 53% yield as yellow prisms (dioxane), mp 200–201 8C,
IR to be identical to the product 11 obtained from 3-
chloroflavazole.
3
.1.3. General procedure of alkylation of 3-halo-1H-
pyrazolo[3,4-b]quinoxalines (11–13). To a solution of
-halo-1H-pyrazolo[3,4-b]quinoxaline (10 mmol) in N,N-
dimethylformamide (30 mL) the alkylating agent
3
3
.1.4.2. 3-Bromo-1-tert-butyl-1H-pyrazolo[3,4-b]-
quinoxaline (14). From NBS (3.4 mmol, 0.60 g) and 4
0.68 g) in 48% yield as yellow needles (ethanol), mp 192–
(
(
15 mmol) and powdered anhydrous potassium carbonate
20 mmol, 2.76 g) were added. The mixture was stirred over
(
1
2
(
(
C
2
4 h at 50 8C and then diluted with water (50 mL). The
93.5 8C; ms: m/z (%) 307 (30) (MC3) , 306 (100) (MC
) , 305 (30) (MC1) , 304 (100) M , 291 (15), 289 (15)
C
C
C
precipitate was collected by filtration, treated with cold 2 N
NaOH, washed with water until neutral and dried.
C
C
MKCH ) , 250 (50), 248 (48) (MKC H ) , 169 (30)
3 4 8
C
248–Br) , 143 (20), 102 (22), 90 (25); IR: 3068, 2975,
3
.1.3.1. 3-Chloro-1-methyl-1H-pyrazolo[3,4-b]quin-
2933, 2683, 1967, 1715, 1622, 1565, 1494, 1477, 1436,
1414, 1388, 1368, 1348, 1292, 1258, 1233, 1198, 1148,
1122, 1068, 1025, 928, 871, 803, 759, 728, 606, 589, 496,
425. Elemental analysis (%) for C13H13BrN : calcd C 51.16,
4
H 4.29, N 18.36; found C 50.93, H 4.41, N 18.65.
oxaline (11). From 5 (2.04 g) and methyl iodide (2.13 g)
in 57% yield as yellow prisms (dioxane), mp 200–201 8C;
ms: m/z 220 (26) (MC2) , 219 (16) (MC1) , 218 (76)
C
C
C
C
C
M , 217 (19) (MK1) , 183 (15) (MKCl) , 129 (33), 102
18), 90 (14), 76 (11), 63 (11); IR: 3047, 2940, 1978, 1732,
(
1
1
5
574, 1488, 1462, 1400, 1352, 1302, 1242, 1208, 1166,
116, 1022, 940, 892, 846, 818, 768, 722, 658, 626, 602,
52, 528, 488, 424. Elemental analysis (%) for C H ClN :
3.1.4.3. 1-(4-Bromophenyl)-3-methyl-1H-pyrazolo-
[3,4-b]quinoxaline (16). Solutions of 15 (2.60 g,
10 mmol) in acetic acid (400 mL) and bromine (1.76 g,
1
0
7
4